Skip to main content
OpenTrials
Completed

NCT Number: NCT06468878

Virtual Reality Intervention for Fear of Heights

Exposure-based cognitive behavior therapy is an efficacious treatment for acrophobia (fear of heights) and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate the effects of liked, non-lyrical background music on the efficacy of a brief VR exposure intervention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Boston University

Boston, Massachusetts, 02215, United States

About this study

The goal of this clinical trial is to compare acrophobia (fear of heights) outcomes for VR exposure therapy in college students with elevated acrophobia when listening to music during exposure versus no music. The overarching aim of the current study is to determine how liked, non-lyrical background music will influence acrophobia outcomes after a brief exposure therapy session in VR.

The study involves three phases: (1) initial screening, (2) in-person assessment and a brief exposure intervention for a subset of participants with elevated acrophobia, and (3) a one-week follow-up assessment conducted online. Students who choose to participate and screen high on an acrophobia scale will be assigned to an experimental or control condition prior to undergoing VR based exposure therapy. Acrophobia outcomes are measured immediately post-intervention and one week later.

Researchers will compare participants in the music condition to participants in the non-music condition to see if acrophobia outcomes differ.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Self-report of 18 years of age or older
  • Current student at Boston University
  • Ability to read English to provide informed consent
  • Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet)
  • For Phase 2: Acrophobia score of ≥ 45.45 on the Acrophobia Questionnaire (AQ) Anxiety Subscale

Exclusion criteria

  • Previous participation (i.e. no participant may take the survey more than once).

Treatment and study plan

Exposure Intervention Plus Music Induction

Behavioral

VR exposure for acrophobia with background music.

Exposure Intervention With No Music Induction

Behavioral

VR exposure for acrophobia with no background music.

Primary outcomes

  1. Acrophobia (Fear of Heights)

    Time frame: Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure

    Assessed using the Acrophobia Questionnaire (AQ) Anxiety Subscale

Secondary outcomes

  1. Valance

    Time frame: Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure

    Self-report measure of how participant feels about experiencing high-height environments.

  2. Height-Relevant Interpretations

    Time frame: Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure

    Assessed using the Heights Interpretation Questionnaire (HIQ)

Sponsors and collaborators

Lead sponsor

Boston University Charles River Campus

Other

Registry information

Official study title

The Influence of Music on Response to Virtual Reality-Based Exposure for Acrophobia

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 21, 2024
Registry last updated
Jun 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.